CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-002216
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
 CAA68374.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA31830.1; CAA30050.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59502.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; AAB59501.1; BAA22264.1; BAG35248.1; BAG58500.1; AAW82435.1; EAX09958.1; EAX09959.1; EAX09960.1; EAX09961.1; EAX09963.1; EAX09965.1; AAH04369.1; AAH65529.1; AAA60163.1; AAC13654.1; AAC13654.1; AAA58727.1; CAA30042.1; CAA30041.1; AAA51726.1; AAA51768.1; AAA51768.1; BAB71958.2; AAA35540.1; AAA51564.1; AAA51727.1; AAA51727.1; AAB23646.1; AAC60601.2; AAQ14327.1; AAB26263.2; AAB26264.2; AAB26265.2; AAA51722.1 
Protein Name
 Amyloid beta A4 protein 
Protein Synonyms/Alias
 ABPP; APPI; APP; Alzheimer disease amyloid protein; Cerebral vascular amyloid peptide; CVAP; PreA4; Protease nexin-II; PN-II; N-APP; Soluble APP-alpha; S-APP-alpha; Soluble APP-beta; S-APP-beta; C99; Beta-amyloid protein 42; Beta-APP42; Beta-amyloid protein 40; Beta-APP40; C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59; Amyloid intracellular domain 59; AICD-59; AID(59); Gamma-CTF(59); Gamma-secretase C-terminal fragment 57; Amyloid intracellular domain 57; AICD-57; AID(57); Gamma-CTF(57); Gamma-secretase C-terminal fragment 50; Amyloid intracellular domain 50; AICD-50; AID(50); Gamma-CTF(50); C31 
Gene Name
 APP 
Gene Synonyms/Alias
 A4; AD1 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
662GSGLTNIKTEEISEVsumoylation[1]
670TEEISEVKMDAEFRHsumoylation[1]
751PEERHLSKMQQNGYEubiquitination[2, 3, 4, 5, 6]
763GYENPTYKFFEQMQNubiquitination[2, 3, 5, 6]
Reference
 [1] SUMO and its role in human diseases.
 Sarge KD, Park-Sarge OK.
 Int Rev Cell Mol Biol. 2011;288:167-83. [PMID: 21482412]
 [2] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [3] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [4] Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.
 Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR.
 J Biol Chem. 2011 Dec 2;286(48):41530-8. [PMID: 21987572]
 [5] Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.
 Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, Nielsen ML, Bekker-Jensen S, Mailand N, Choudhary C.
 Nat Cell Biol. 2012 Oct;14(10):1089-98. [PMID: 23000965]
 [6] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties.
 Chen Z, Zhou Y, Song J, Zhang Z.
 Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [PMID: 23603789
Functional Description
 Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1. Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER- dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. 
Sequence Annotation
 DOMAIN 291 341 BPTI/Kunitz inhibitor.
 REGION 96 110 Heparin-binding.
 REGION 181 188 Zinc-binding.
 REGION 391 423 Heparin-binding.
 REGION 491 522 Heparin-binding.
 REGION 523 540 Collagen-binding.
 REGION 732 751 Interaction with G(o)-alpha.
 MOTIF 724 734 Basolateral sorting signal.
 MOTIF 759 762 NPXY motif; contains endocytosis signal.
 METAL 147 147 Copper 1.
 METAL 151 151 Copper 1.
 METAL 168 168 Copper 1.
 METAL 677 677 Copper or zinc 2.
 METAL 681 681 Copper or zinc 2 (Probable).
 METAL 684 684 Copper or zinc 2.
 METAL 685 685 Copper or zinc 2.
 MOD_RES 198 198 Phosphoserine; by CK2.
 MOD_RES 206 206 Phosphoserine; by CK1.
 MOD_RES 729 729 Phosphothreonine (By similarity).
 MOD_RES 730 730 Phosphoserine; by APP-kinase I (By
 MOD_RES 743 743 Phosphothreonine; by CDK5 and MAPK10.
 MOD_RES 757 757 Phosphotyrosine; alternate.
 MOD_RES 757 757 Phosphotyrosine; by ABL1; alternate (By
 CARBOHYD 542 542 N-linked (GlcNAc...).
 CARBOHYD 571 571 N-linked (GlcNAc...) (Probable).
 CARBOHYD 614 614 O-linked (GalNAc...).
 CARBOHYD 623 623 O-linked (GalNAc...).
 CARBOHYD 628 628 O-linked (GalNAc...).
 CARBOHYD 633 633 O-linked (GalNAc...).
 CARBOHYD 651 651 O-linked (GalNAc...).
 CARBOHYD 652 652 O-linked (GalNAc...).
 CARBOHYD 656 656 O-linked (Xyl...) (chondroitin sulfate);
 CARBOHYD 659 659 O-linked (GalNAc...).
 CARBOHYD 663 663 O-linked (GalNAc...) (Probable).
 CARBOHYD 667 667 O-linked (GalNAc...) (Probable).
 CARBOHYD 679 679 O-linked (GalNAc...).
 CARBOHYD 697 697 O-linked (GalNAc...).
 DISULFID 38 62
 DISULFID 73 117
 DISULFID 98 105
 DISULFID 133 187
 DISULFID 144 174
 DISULFID 158 186
 DISULFID 291 341
 DISULFID 300 324
 DISULFID 316 337  
Keyword
 3D-structure; Alternative splicing; Alzheimer disease; Amyloid; Amyloidosis; Apoptosis; Cell adhesion; Coated pit; Complete proteome; Copper; Direct protein sequencing; Disease mutation; Disulfide bond; Endocytosis; Glycoprotein; Heparin-binding; Iron; Membrane; Metal-binding; Neurodegeneration; Notch signaling pathway; Phosphoprotein; Polymorphism; Protease inhibitor; Proteoglycan; Reference proteome; Serine protease inhibitor; Signal; Transmembrane; Transmembrane helix; Zinc. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 770 AA 
Protein Sequence
MLPGLALLLL AAWTARALEV PTDGNAGLLA EPQIAMFCGR LNMHMNVQNG KWDSDPSGTK 60
TCIDTKEGIL QYCQEVYPEL QITNVVEANQ PVTIQNWCKR GRKQCKTHPH FVIPYRCLVG 120
EFVSDALLVP DKCKFLHQER MDVCETHLHW HTVAKETCSE KSTNLHDYGM LLPCGIDKFR 180
GVEFVCCPLA EESDNVDSAD AEEDDSDVWW GGADTDYADG SEDKVVEVAE EEEVAEVEEE 240
EADDDEDDED GDEVEEEAEE PYEEATERTT SIATTTTTTT ESVEEVVREV CSEQAETGPC 300
RAMISRWYFD VTEGKCAPFF YGGCGGNRNN FDTEEYCMAV CGSAMSQSLL KTTQEPLARD 360
PVKLPTTAAS TPDAVDKYLE TPGDENEHAH FQKAKERLEA KHRERMSQVM REWEEAERQA 420
KNLPKADKKA VIQHFQEKVE SLEQEAANER QQLVETHMAR VEAMLNDRRR LALENYITAL 480
QAVPPRPRHV FNMLKKYVRA EQKDRQHTLK HFEHVRMVDP KKAAQIRSQV MTHLRVIYER 540
MNQSLSLLYN VPAVAEEIQD EVDELLQKEQ NYSDDVLANM ISEPRISYGN DALMPSLTET 600
KTTVELLPVN GEFSLDDLQP WHSFGADSVP ANTENEVEPV DARPAADRGL TTRPGSGLTN 660
IKTEEISEVK MDAEFRHDSG YEVHHQKLVF FAEDVGSNKG AIIGLMVGGV VIATVIVITL 720
VMLKKKQYTS IHHGVVEVDA AVTPEERHLS KMQQNGYENP TYKFFEQMQN 770 
Gene Ontology
 GO:0045177; C:apical part of cell; IEA:Compara.
 GO:0030424; C:axon; ISS:UniProtKB.
 GO:0009986; C:cell surface; IDA:UniProtKB.
 GO:0035253; C:ciliary rootlet; IEA:Compara.
 GO:0005905; C:coated pit; IEA:UniProtKB-SubCell.
 GO:0005829; C:cytosol; TAS:Reactome.
 GO:0043198; C:dendritic shaft; IDA:MGI.
 GO:0043197; C:dendritic spine; IDA:MGI.
 GO:0005576; C:extracellular region; TAS:Reactome.
 GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
 GO:0005887; C:integral to plasma membrane; TAS:ProtInc.
 GO:0031594; C:neuromuscular junction; IEA:Compara.
 GO:0048471; C:perinuclear region of cytoplasm; IEA:Compara.
 GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
 GO:0051233; C:spindle midzone; IEA:Compara.
 GO:0045202; C:synapse; IDA:MGI.
 GO:0003677; F:DNA binding; ISS:UniProtKB.
 GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
 GO:0016504; F:peptidase activator activity; IEA:Compara.
 GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
 GO:0046914; F:transition metal ion binding; IEA:InterPro.
 GO:0008344; P:adult locomotory behavior; ISS:UniProtKB.
 GO:0008088; P:axon cargo transport; ISS:UniProtKB.
 GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
 GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
 GO:0006878; P:cellular copper ion homeostasis; ISS:UniProtKB.
 GO:0008203; P:cholesterol metabolic process; IEA:Compara.
 GO:0048669; P:collateral sprouting in absence of injury; ISS:UniProtKB.
 GO:0016358; P:dendrite development; ISS:UniProtKB.
 GO:0006897; P:endocytosis; ISS:UniProtKB.
 GO:0030198; P:extracellular matrix organization; ISS:UniProtKB.
 GO:0030900; P:forebrain development; IEA:Compara.
 GO:0000085; P:G2 phase of mitotic cell cycle; ISS:UniProtKB.
 GO:0006917; P:induction of apoptosis; IEA:Compara.
 GO:0045087; P:innate immune response; TAS:Reactome.
 GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB.
 GO:0007617; P:mating behavior; ISS:UniProtKB.
 GO:0006378; P:mRNA polyadenylation; ISS:UniProtKB.
 GO:0045665; P:negative regulation of neuron differentiation; IEA:Compara.
 GO:0050885; P:neuromuscular process controlling balance; IEA:Compara.
 GO:0051402; P:neuron apoptotic process; IMP:UniProtKB.
 GO:0016322; P:neuron remodeling; ISS:UniProtKB.
 GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
 GO:0035872; P:nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway; TAS:Reactome.
 GO:0030168; P:platelet activation; TAS:Reactome.
 GO:0002576; P:platelet degranulation; TAS:Reactome.
 GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB.
 GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Compara.
 GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
 GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB.
 GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB.
 GO:0043393; P:regulation of protein binding; IEA:Compara.
 GO:0050803; P:regulation of synapse structure and activity; ISS:UniProtKB.
 GO:0006417; P:regulation of translation; ISS:UniProtKB.
 GO:0006979; P:response to oxidative stress; IEA:Compara.
 GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IEA:Compara.
 GO:0001967; P:suckling behavior; IEA:Compara.
 GO:0051124; P:synaptic growth at neuromuscular junction; IEA:Compara.
 GO:0008542; P:visual learning; ISS:UniProtKB. 
Interpro
 IPR008155; Amyloid_glyco.
 IPR013803; Amyloid_glyco_Abeta.
 IPR011178; Amyloid_glyco_Cu-bd.
 IPR024329; Amyloid_glyco_E2_domain.
 IPR008154; Amyloid_glyco_extra.
 IPR019744; Amyloid_glyco_extracell_CS.
 IPR015849; Amyloid_glyco_heparin-bd.
 IPR019745; Amyloid_glyco_intracell_CS.
 IPR019543; APP_amyloid_C.
 IPR002223; Prot_inh_Kunz-m.
 IPR020901; Prtase_inh_Kunz-CS. 
Pfam
 PF10515; APP_amyloid
 PF12924; APP_Cu_bd
 PF12925; APP_E2
 PF02177; APP_N
 PF03494; Beta-APP
 PF00014; Kunitz_BPTI 
SMART
 SM00006; A4_EXTRA
 SM00131; KU 
PROSITE
 PS00319; A4_EXTRA
 PS00320; A4_INTRA
 PS00280; BPTI_KUNITZ_1
 PS50279; BPTI_KUNITZ_2 
PRINTS
 PR00203; AMYLOIDA4.
 PR00759; BASICPTASE.
 PR00204; BETAAMYLOID.